Literature DB >> 23780339

MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells.

S-Y Wu1, K-C Lin, J-F Chiou, S-C Jeng, W-H Cheng, C-I Chang, W-C Lin, L-L Wu, H-L Lee, R-J Chen.   

Abstract

BACKGROUND AND
PURPOSE: Betel nut chewing is associated with oral cavity cancer in Taiwan. OC3 is an oral carcinoma cell line that was established from cells collected from a long-term betel nut chewer who does not smoke. After we found that microRNA-17-5p (miR-17-5p) is induced in OC3 cells, we used this cell line to examine the biological role(s) of this microRNA in response to exposure to ionizing radiation.
MATERIALS AND METHODS: A combined SYBR green-based real-time PCR and oligonucleotide ligation assay was used to examine the expression of the miR-17 polycistron in irradiated OC3 cells. The roles of miR-17-5p and p21 were evaluated with specific antisense oligonucleotides (ODN) that were designed and used to inhibit their expression. Expression of the p21 protein was evaluated by Western blotting. The clonogenic assay and annexin V staining were used to evaluate cell survival and apoptosis, respectively. Cells in which miR-17-5p was stably knocked down were used to create ectopic xenografts to evaluate in vivo the role of miR-17-5p.
RESULTS: A radiation dose of 5 Gy significantly increased miR-17-5p expression in irradiated OC3 cells. Inhibition of miR-17-5p expression enhanced the radiosensitivity of the OC3 cells. We found that miR-17-5p downregulates radiation-induced p21 expression in OC3 cells and, by using a tumor xenograft model, it was found that p21 plays a critical role in increasing the radiosensitivity of OC3 cells in vitro and in vivo.
CONCLUSION: miR-17-5p is induced in irradiated OC3 cells and it downregulates p21 protein expression, contributing to the radioresistance of OC3 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23780339     DOI: 10.1007/s00066-013-0347-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

Review 2.  MicroRNA and oral cancer: future perspectives.

Authors:  Carolina C Gomes; Ricardo S Gomez
Journal:  Oral Oncol       Date:  2008-07-11       Impact factor: 5.337

3.  Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.

Authors:  G Lossaint; E Besnard; D Fisher; J Piette; V Dulić
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

4.  Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.

Authors:  Jeffrey T Wang; Carsten E Palme; Gary J Morgan; Val Gebski; Allen Y Wang; Michael J Veness
Journal:  Head Neck       Date:  2011-11-23       Impact factor: 3.147

5.  The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.

Authors:  Piu Wong; Masayuki Iwasaki; Tim C P Somervaille; Francesca Ficara; Christine Carico; Christopher Arnold; Chang-Zheng Chen; Michael L Cleary
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

6.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

8.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

9.  The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.

Authors:  Dong Yang; Mingjia Tan; Gongxian Wang; Yi Sun
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

10.  Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.

Authors:  Laura Fontana; Micol E Fiori; Sonia Albini; Loredana Cifaldi; Serena Giovinazzi; Matteo Forloni; Renata Boldrini; Alberto Donfrancesco; Valentina Federici; Patrizio Giacomini; Cesare Peschle; Doriana Fruci
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  9 in total

Review 1.  Multiple functions of p21 in cancer radiotherapy.

Authors:  Yanbei Kuang; Jian Kang; Hongbin Li; Bingtao Liu; Xueshan Zhao; Linying Li; Xiaodong Jin; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-05       Impact factor: 4.553

2.  MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.

Authors:  Te Liu; Wenxing Qin; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-12-16

3.  Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells.

Authors:  Szu-Yuan Wu; Alexander T H Wu; Kevin Sheng-Po Yuan; Shing Hwa Liu
Journal:  J Cancer       Date:  2016-12-09       Impact factor: 4.207

Review 4.  MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.

Authors:  Parwez Ahmad; Jiri Sana; Marek Slavik; Pavel Slampa; Pavel Smilek; Ondrej Slaby
Journal:  Dis Markers       Date:  2017-02-23       Impact factor: 3.434

5.  Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.

Authors:  Qiuling Wang; Jingxin Han; Pu Xu; Xinchun Jian; Xieshan Huang; Deyu Liu
Journal:  Cancer Manag Res       Date:  2021-02-22       Impact factor: 3.989

6.  The Silencing Effect of microRNA miR-17 on p21 Maintains the Neural Progenitor Pool in the Developing Cerebral Cortex.

Authors:  Yase Chen; Shan Bian; Jing Zhang; Haijun Zhang; Beisha Tang; Tao Sun
Journal:  Front Neurol       Date:  2014-07-18       Impact factor: 4.003

7.  MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing.

Authors:  Szu-Yuan Wu; Alexander T H Wu; Shing-Hwa Liu
Journal:  Oncotarget       Date:  2016-08-09

Review 8.  Targeting MicroRNAs in Prostate Cancer Radiotherapy.

Authors:  Jie Ni; Joseph Bucci; Lei Chang; David Malouf; Peter Graham; Yong Li
Journal:  Theranostics       Date:  2017-07-23       Impact factor: 11.556

9.  Upregulation of microRNA-17-5p contributes to hypoxia-induced proliferation in human pulmonary artery smooth muscle cells through modulation of p21 and PTEN.

Authors:  Guangjie Liu; Peng Hao; Jie Xu; Liming Wang; Yuchuan Wang; Ruifang Han; Ming Ying; Shuangshuang Sui; Jinghua Liu; Xuan Li
Journal:  Respir Res       Date:  2018-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.